Involvement of oxysterols in age-related diseases and ageing processes

Ageing Research Reviews

Volumn 18, Issue , 2014, Pages 148-162

  Zarrouk, Amira ^a,b,c   Vejux, Anne ^a   Mackrill, John ^b   O'Callaghan, Yvonne ^b   Hammami, Mohamed ^c   O'Brien, Nora ^b   Lizard, Gérard ^a  

^a Faculté des Sciences Gabriel   (France)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY OF MONASTIR   (Tunisia)

Author keywords

Age related diseases; Ageing; Oxysterols

Indexed keywords

OXYSTEROL; CHOLESTEROL;

AEROBIC METABOLISM; AGE RELATED MACULAR DEGENERATION; AGING; ALZHEIMER DISEASE; ANGIOGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CATARACT; CATARACTOGENESIS; CELL DEATH; CYTOTOXICITY; HOMEOSTASIS; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; LIFE EXPECTANCY; LIPID METABOLISM; LIPID PEROXIDATION; MITOCHONDRION; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOPOROSIS; OXIDATION; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; AGE; ANIMAL; DISEASES; HEALTH STATUS; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; SIGNAL TRANSDUCTION;

AGE FACTORS; AGING; ANIMALS; CHOLESTEROL; DISEASE; HEALTH STATUS; HUMANS; OXIDATION-REDUCTION; SIGNAL TRANSDUCTION;

EID: 84908238928     PISSN: 15681637     EISSN: 18729649     Source Type: Journal    
DOI: 10.1016/j.arr.2014.09.006     Document Type: Review

References (227)

1. Abad-Rodriguez J., Ledesma M.D., Craessaerts K., Perga S., Medina M., Delacourte A., Dingwall C., De Strooper B., Dotti C.G. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J. Cell Biol. 2004, 167:953-960.
2. Abuznait A.H., Kaddoumi A. Role of ABC transporters in the pathogenesis of Alzheimer's disease. ACS Chem. Neurosci. 2012, 3:820-831.
3. Aghaloo T.L., Amantea C.M., Cowan C.M., Richardson J.A., Wu B.M., Parhami F., Tetradis S. Oxysterols enhance osteoblast differentiation in vitro and bone healing in vivo. J. Orthop. Res. 2007, 25:1488-1497.
4. Alexandrov P., Cui J.G., Zhao Y., Lukiw W.J. 24S-hydroxycholesterol induces inflammatory gene expression in primary human neural cells. NeuroReport 2005, 16:909-913.
5. Amantea C.M., Kim W.K., Meliton V., Tetradis S., Parhami F. Oxysterol-induced osteogenic differentiation of marrow stromal cells is regulated by Dkk-1 inhibitable and PI3-kinase mediated signaling. J. Cell. Biochem. 2008, 105:424-436.
6. Bartzokis G. Alzheimer's disease as homeostatic responses to age-related myelin breakdown. Neurobiol. Aging 2011, 32:1341-1371.
7. Berzelius J.J. Lehrbuch der Chemie 1825-1831, 525. Arnold, Dresden.
8. Björkhem I., Einarsson K., Johansson G. Formation and metabolism of 3-beta-hydroxycholest-5-en-7-one and cholest-5-ene-3-beta, 7-beta-diol Bile acids and steroids 192. Acta Chem. Scand. 1968, 22:1594-1605.
9. Björkhem I., Lütjohann D., Diczfalusy U., Ståhle L., Ahlborg G., Wahren J. Cholesterol homeostasis in human brain: turnover of 24Shydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 1998, 39:1594-1600.
10. Björkhem I., Meaney S. Brain cholesterol: long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol. 2004, 24:806-815.
11. Björkhem I. Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J. Intern. Med. 2006, 260:493-508.
12. Björkhem I. Are side-chain oxidized oxysterols regulators also in vivo?. J. Lipid Res. 2009, 50:S213-S218.
13. Blennow K., De Leon M.J., Zetterberg H. Alzheimer's disease. Lancet 2006, 368:387-403.
14. Boccardi V., Paolisso G. Telomerase activation: a potential key modulator for human healthspan and longevity. Ageing Res. Rev. 2014, 15C:1-5.
15. Bodovitz S., Klein W.L. Cholesterol modulates alpha-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 1996, 271:4436-4440.
16. Bogdanovic N., Bretillon L., Lund E.G., Diczfalusy U., Lannfelt L., Winblad B., Russell D.W., Björkhem I. On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells. Neurosci. Lett. 2001, 314:45-48.
17. Boitard C. Insulin secretion in type 2 diabetes: clinical aspects. Diabetes Metab. 2002, 28. 4S33-4S38.
18. Boumhras M. Evaluation de la toxicité de moules de la CÔte Atlantique Marocaine utilisées comme bioindicateurs de contamination: étude in vivo et in vitro sur des rongeurs et des cellules béta-pancréatiques murines (MIN-6) 2012, University of Bourgogne, University of Settat, Dijon, France/Marocco, (Ph.D. Thesis).
19. Bretillon L., Sidén A., Wahlund L.O., Lütjohann D., Minthon L., Crisby M., Hillert J., Groth C.G., Diczfalusy U., Björkhem I. Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci. Lett. 2000, 293:87-90.
20. Bretillon L., Diczfalusy U., Björkhem I., Maire M.A., Martine L., Joffre C., Acar N., Bron A., Creuzot-Garcher C. Cholesterol-24S-hydroxylase (CYP46A1) is specifically expressed in neurons of the neural retina. Curr. Eye Res. 2007, 32:361-366.
21. Brian G., Taylor H. Cataract blindness-challenges for the 21st century. Bull. World Health Organ. 2001, 79:249-256.
22. Brown A.J., Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 1999, 142:1-28.
23. Brown J., Theisler C., Silberman S., Magnuson D., Gottardi-Littell N., Lee J.M., Yager D., Crowley J., Sambamurti K., Rahman M.M., Reiss A.B., Eckman C.B., Wolozin B. Differential expression of cholesterol hydroxylases in Alzheimer's disease. J. Biol. Chem. 2004, 279:34674-34681.
24. Bu G. Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy. Nat. Rev. Neurosci. 2009, 10:333-344.
25. Burns M., Duff.K. Cholesterol in Alzheimer's disease and tauopathy. Ann. N.Y. Acad. Sci. 2002, 977:367-375.
26. Buttari B., Segoni L., Profumo E., D'Arcangelo D., Rossi S., Facchiano F., Businaro R., Iuliano L., Riganò R. 7-Oxo-cholesterol potentiates pro-inflammatory signaling in human M1 and M2 macrophages. Biochem. Pharmacol. 2013, 86:130-137.
27. Catarino S., Bento C.F., Brito A., Murteira E., Fernandes A.F., Pereira P. Regulation of the expression of interleukin-8 induced by 25-hydroxycholesterol in retinal pigment epithelium cells. Acta Ophtalmol. 2012, 90:255-263.
28. Cenedella R.J. Cholesterol and cataracts. Surv. Ophthalmol. 1996, 40:320-337.
29. Cheng Y.W., Kang J.J., Shih Y.L., Lo Y.L., Wang C.F. Cholesterol-3-beta, 5-alpha, 6-beta-triol induced genotoxicity through reactive oxygen species formation. Food Chem. Toxicol. 2005, 43:617-622.
30. Curcio C.A., Presley J.B., Malek G., Medeiros N.E., Avery D.V., Kruth H.S. Esterified and unesterified cholesterol in drusen and basal deposits of eyes with age-related maculopathy. Exp. Eye Res. 2005, 81:731-741.
31. Dasari B., Prasanthi J.R., Marwarha G., Singh B.B., Ghribi O. The oxysterol 27-hydroxycholesterol increases beta-amyloid and oxidative stress in retinal pigment epithelial cells. BMC Ophthalmol. 2010, 10:22.
32. Dasari B., Prasanthi J.R., Marwarha G., Singh B.B., Ghribi O. Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina. BMC Ophthalmol. 2011, 11:22.
33. Daugvilaite V., Arfelt K.N., Benned-Jensen T., Sailer A.W., Rosenkilde M.M. EBI2-targeting oxysterols: a moving story. Eur. J. Immunol. 2014, 10.1002/eji.201444493.
34. De Boussac H., Alioui A., Viennois E., Dufour J., Trousson A., Vega A., Guy L., Volle D.H., Lobaccaro J.M., Baron S. Oxysterol receptors and their therapeutic applications in cancer conditions. Expert Opin. Ther. Targets 2013, 17:1029-1038.
35. De Boussac H., Pommier A.J., Dufour J., Trousson A., Caira F., Volle D.H., Baron S., Lobaccaro J.M. LXR, prostate cancer and cholesterol: the good, the bad and the ugly. Am. J. Cancer Res. 2013, 3:58-69.
36. Deckert V., Perségol L., Viens L., Lizard G., Athias A., Lallemant C., Gambert P., Lagrost L. Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins Cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation. Circulation 1997, 95:723-731.
37. Deckert V., Duverneuil L., Poupon S., Monier S., Le Guern N., Lizard G., Masson D., Lagrost L. The impairment of endothelium-dependent arterial relaxation by 7-ketocholesterol is associated with an early activation of protein kinase C. Br. J. Pharmacol. 2002, 137:655-662.
38. De Medina P., Paillasse M.R., Ségala G., Khallouki F., Brillouet S., Dalenc F., Courbon F., Record M., Poirot M., Silvente-Poirot S. Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands. Chem. Phys. Lipids 2011, 164:432-437.
39. De Medina P., Paillasse M.R., Segala G., Voisin M., Mhamdi L., Dalenc F., Lacroix-Triki M., Filleron T., Pont F., Saati T.A., Morisseau C., Hammock B.D., Silvente-Poirot S., Poirot M. Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties. Nat. Commun. 2013, 24:1840.
40. Dentchev T., Milam A.H., Lee V.M., Trojanowski J.Q., Dunaief J.L. Amyloid-beta is found in drusen from some age-related macular degeneration retinas, but not in drusen from normal retinas. Mol. Vision 2003, 9:184-190.
41. Di Frisco S., De Ruggieri P., Ercolli A. Isolation of cerebrosterol from human brain. Boll. Soc. Ital Biol. Sper. 1953, 29:1351-1352.
42. Di Paolo G., Kim T.W. Linking lipids to Alzheimer's disease: cholesterol and beyond. Nat. Rev. Neurosci. 2011, 12:284-296.
43. Diczfalusy U. On the formation and possible biological role of 25-hydroxycholesterol. Biochimie 2013, 95:455-460.
44. Ding X., Patel M., Chan C.C. Molecular pathology of age-related macular degeneration. Prog. Retin. Eye. Res. 2009, 28:1-18.
45. Dreyfus M.A., Tolocka M.P., Dodds S.M., Dykins J., Johnston M.V. Cholesterol ozonolysis: kinetics, mechanism, and oligomer products. J. Phys. Chem. A 2005, 109:6242-6248.
46. Dufour J., Viennois E., De Boussac H., Baron S., Lobaccaro J.M. Oxysterol receptors AKT and prostate cancer. Curr. Opin. Pharmacol. 2012, 12:724-728.
47. Dugas B., Charbonnier S., Baarine M., Ragot K., Delmas D., Ménétrier F., Lherminier J., Malvitte L., Khalfaoui T., Bron A., Creuzot-Garcher C., Latruffe N., Lizard G. Effects of oxysterols on cell viability, inflammatory cytokines, VEGF, and reactive oxygen species production on human retinal cells: cytoprotective effects and prevention of VEGF secretion by resveratrol. Eur. J. Nutr. 2010, 49:435-446.
48. Duran M.J., Pierre S.V., Lesnik P., Pieroni G., Bourdeaux M., Dignat-Georges F., Sampol J., Maixent J.M. ketocholesterol inhibits Na K-ATPase activity by decreasing expression of its α1-subunit and membrane fluidity in human endothelial cells. Cell. Mol. Biol. 2010, 56:1434-1441.
49. DuSell C.D., Nelson E.R., Wang X., Abdo J., Mödder U.I., Umetani M., Gesty-Palmer D., Javitt N.B., Khosla S., McDonnell D.P. The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis. Endocrinology 2010, 151:3675-3685.
50. Ehrlich D., Humpel C. Chronic vascular risk factors (cholesterol, homocysteine, ethanol) impair spatial memory, decline cholinergic neurons and induce blood-brain barrier leakage in rats in vivo. J. Neurol. Sci. 2012, 322:92-95.
51. Ehehalt R., Keller P., Haass C., Thiele C., Simons K. Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts. J. Cell Biol. 2003, 160:113-123.
52. Famer D., Meaney S., Mousavi M., Nordberg A., Bjorkhem I., Crisby M. Regulation of alpha- and beta-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the alpha-secretase pathway. Biochem. Biophys. Res. Commun. 2007, 359:46-50.
53. Fassbender K., Simons M., Bergmann C., Stroick M., Lutjohann D., Keller P., Runz H., Kuhl S., Bertsch T., von Bergmann K., Hennerici M., Beyreuther K., Hartmann T. Simvastatin strongly reduces levels of Alzheimer's disease beta-amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 2001, 98:5856-5861.
54. Feldman G.L., Feldman L.S. New concepts of human lenticular lipids and their possible role in cataract. Invest. Ophtalmol. 1965, 4:162-166.
55. Fiolaki A., Tsamis K.I., Milionis H.J., Kyritsis A.P., Kosmidou M., Giannopoulos S. Atherosclerosis, biomarkers of atherosclerosis and Alzheimer's disease. Int. J. Neurosci. 2014, 124:1-11.
56. Fiorenza M.T., Dardis A., Canterini S., Erickson R.P. Cholesterol metabolism-associated molecules in late onset Alzheimer's disease. J. Biol. Regul. Homeost. Agents 2013, 27:23-35.
57. Fotenos A., Snyder A. Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD. Neurology 2005, 64:1032-1039.
58. Fourgeux C., Martine L., Acar N., Bron A.M., Creuzot-Garcher C.P., Bretillon L. In vivo consequences of cholesterol-24S-hydroxylase (CYP46A1) inhibition by voriconazole on cholesterol homeostasis and function in the rat retina. Biochem. Biophys. Res. Commun. 2014, 446:775-781.
59. Freeman M.R., Solomon K.R. Cholesterol and prostate cancer. J. Cell Biochem. 2004, 91:54-69.
60. Galea E., Launay N., Portero-Otin M., Ruiz M., Pamplona R., Aubourg P., Ferrer I., Pujol A. Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases?. Biochim. Biophys. Acta 2012, 1822:1475-1488.
61. Gamba P., Guglielmotto M., Testa G., Monteleone D., Zerbinati C., Gargiulo S., Biasi F., Iuliano L., Giaccone G., Mauro A., Poli G., Tamagno E., Leonarduzzi G. Up-regulation of β-amyloidogenesis in neuron-like human cells by both 24- and 27-hydroxycholesterol: protective effect of N-acetyl-cysteine. Aging Cell 2014, 13:561-572.
62. Gao C., Hölscher C., Liu Y., Li L. GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer disease. Rev. Neurosci. 2011, 23:1-11.
63. Garcia A., Muniz M., Souzae Silva H., Da Silva H., Athayde-Junior L. Cyp46 polymorphisms in Alzheimer's disease: a review. J. Mol. Neurosci. 2009, 39:342-345.
64. Gargiulo S., Sottero B., Gamba P., Chiarpotto E., Poli G., Leonarduzzi G. Plaque oxysterols induce unbalanced up-regulation of matrix metalloproteinase-9 in macrophagic cells through redox-sensitive signaling pathways: implications regarding the vulnerability of atherosclerotic lesions. Free Radic. Biol. Med. 2011, 51:844-855.
65. Gargiulo S., Gamba P., Poli G., Leonarduzzi G. Metalloproteinases and metalloproteinase inhibitors in age-related diseases. Curr. Pharm. Des. 2014, 20:2993-3018.
66. Gatto D., Brink R. B cell localization: regulation by EBI2 and its oxysterol ligand. Trends Immunol. 2013, 34:336-341.
67. Geyeregger R., Zeyda M., Stulnig T.M. Liver X receptors in cardiovascular and metabolic disease. Cell Mol. Life Sci. 2006, 63:524-539.
68. Ghribi O., Larsen B., Schrag M., Herman M.M. High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus. Exp. Neurol. 2006, 200:460-467.
69. Girão H., Mota M.C., Ramalho J., Pereira P. Cholesterol oxides accumulate in human cataracts. Exp. Eye Res. 1998, 66:645-652.
70. Gramajo A.L., Zacharias L.C., Neekhra A., Luthra S., Atilano S.R., Chwa M., Brown D.J., Kuppermann B.D., Kenney M.C. Mitochondrial DNA damage induced by 7-ketocholesterol in human retinal pigment epithelial cells in vitro. Invest. Ophthalmol. Visual Sci. 2010, 51:1164-1170.
71. Hannedouche S., Zhang J., Yi T., Shen W., Nguyen D., Pereira J.P., Guerini D., Baumgarten B.U., Roggo S., Wen B., Knochenmuss R., Noël S., Gessier F., Kelly L.M., Vanek M., Laurent S., Preuss I., Miault C., Christen I., Karuna R., Li W., Koo D.I., Suply T., Schmedt C., Peters E.C., Falchetto R., Katopodis A., Spanka C., Roy M.O., Detheux M., Chen Y.A., Schultz P.G., Cho C.Y., Seuwen K., Cyster J.G., Sailer A.W. Oxysterols direct immune cell migration via EBI2. Nature 2011, 475:524-527.
72. Harman D. The free radical theory of aging. Antioxid. Redox Signal. 2003, 5:557-561.
73. Hayden J.M., Brachova L., Higgins K., Obermiller L., Sevanian A., Khandrika S., Reaven P.D. Induction of monocyte differentiation and foam cell formation in vitro by 7-ketocholesterol. J. Lipid Res. 2002, 43:26-35.
74. He C., Zhu H., Zhang W., Okon I., Wang Q., Li H., Le Y.Z., Xie Z. 7 Ketocholesterol induces autophagy in vascular smooth muscle cells through Nox4 and Atg4B. Am. J. Pathol. 2013, 183:626-637.
75. Helmschrodt C., Becker S., Schröter J., Hecht M., Aust G., Thiery J., Ceglarek U. Fast LC-MS/MS analysis of free oxysterols derived from reactive oxygen species in human plasma and carotid plaque. Clin. Chim. Acta 2013, 425:3-8.
76. Heverin M., Bogdanovic N., Lutjohann D., Bayer T., Pikuleva I., Bretillon L., Diczfalusy U., Winblad B., Bjorkhem I. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J. Lipid Res. 2004, 45:186-193.
77. Hoang J.J., Baron S., Volle D.H., Lobaccaro J.M., Trousson A. Lipids, LXRs and prostate cancer: are HDACs a new link?. Biochem. Pharmacol. 2013, 86:168-174.
78. Hu H., Hilton M.J., Tu X., Yu K., Ornitz D.M., Long F. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 2005, 132:49-60.
79. Huang J.D., Amaral J., Lee J.W., Larrayoz I.M., Rodriguez I.R. Sterculic acid antagonizes 7-ketocholesterol-mediated inflammation and inhibits choroidal neovascularization. Biochim. Biophys. Acta 2012, 1821:637-646.
80. Hudry E., Van Dam D., Kulik W., De Deyn P.P., Stet F.S., Ahouansou O., Benraiss A., Delacourte A., Bougnères P., Aubourg P., Cartier N. Adeno-associated virus gene therapy with cholesterol 24-hydroxylase reduces the amyloid pathology before or after the onset of amyloid plaques in mouse models of Alzheimer's disease. Mol. Ther. 2010, 18:44-53.
81. Iuliano L. Pathways of cholesterol oxidation via non-enzymatic mechanisms. Chem. Phys. Lipids 2011, 164:457-468.
82. Jack C.R., Lowe V.J., Weigand S.D., Wiste H.J., Senjem M.L., Knopman D.S., Shiung M.M., Gunter J.L., Boeve B.F., Kemp B.J., Weiner M., Petersen R.C. Alzheimer's Disease Neuroimaging Initiative, Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease, implications for sequence of pathological events in Alzheimer's disease. Brain 2009, 132:1355-1365.
83. Jack C.R., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010, 9:119-128.
84. Javitt N.B., Javitt J.C. The retinal oxysterol pathway: a unifying hypothesis for the cause of age-related macular degeneration. Curr. Opin. Ophthalmol. 2009, 20:151-157.
85. Jenny N.S. Inflammation in aging: cause, effect, or both?. Discovery Med. 2012, 13:451-460.
86. Jia G., Cheng G., Agrawal D.K. Autophagy of vascular smooth muscle cells in atherosclerotic lesions. Autophagy 2007, 3:63-64.
87. Joffre C., Leclère L., Buteau B., Martine L., Cabaret S., Malvitte L., Acar N., Lizard G., Bron A., Creuzot-Garcher C., Bretillon L. Oxysterols induced inflammation and oxidation in primary porcine retinal pigment epithelial cells. Curr. Eye Res. 2007, 32:271-280.
88. Johnson M.L., Harnish K., Nusse R., Van Hul W. LRP5 and Wnt signaling: a union made for bone. J. Bone Miner. Res. 2004, 19:1749-1757.
89. Joseph S.B., Castrillo A., Laffitte B.A., Mangelsdorf D.J., Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 2003, 9:213-219.
90. Jusakul A., Yongvanit P., Loilome W., Namwat N., Kuver R. Mechanisms of oxysterol-induced carcinogenesis. Lipids Health Dis. 2011, 10:44.
91. Kahn E., Ménétrier F., Vejux A., Montange T., Dumas D., Riedinger J.M., Frouin F., Tourneur Y., Brau F., Stoltz J.F., Lizard G. Flow cytometry and spectral imaging multiphoton microscopy analysis of CD36 expression with quantum dots 605 of untreated and 7-ketocholesterol-treated human monocytic cells. Anal. Quant. Cytol. Histol. 2006, 28:316-330.
92. Kha H.T., Basseri B., Shouhed D., Richardson J., Tetradis S., Hahn T.J., Parhami F. Oxysterols regulate differentiation of mesenchymal stem cells: pro-bone and anti-fat. J. Bone Miner. Res. 2004, 19:830-840.
93. Khalifa S.A., de Medina P., Erlandsson A., El-Seedi H.R., Silvente-Poirot S., Poirot M. The novel steroidal alkaloids dendrogenin A and B promote proliferation of adult neural stem cells. Biochem. Biophys. Res. Commun. 2014, 446:681-686.
94. Khatib S., Vaya J. Oxysterols and symptomatic versus asymptomatic human atherosclerotic plaque. Biochem. Biophys. Res. Commun. 2014, 446:709-713.
95. Kim W.K., Meliton V., Amantea C.M., Hahn T.J., Parhami F. 20(S)-hydroxycholesterol inhibits PPARgamma expression and adipogenic differentiation of bone marrow stromal cells through a hedgehog-dependent mechanism. J. Bone Miner. Res. 2007, 22:1711-1719.
96. Kim D.H., Frangos J.A. Effects of amyloid β-peptides on the lysis tension of lipid bilayer vesicles containing oxysterols. Biophys. J. 2008, 95:620-628.
97. Kim W.S., Chan S.L., Hill A.F., Guillemin G.J., Garner B. Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons. J. Alzheimers Dis. 2009, 16:121-131.
98. Kolsch H., Heun R., Kerksiek A., Bergmann K.V., Maier W., Lutjohann D. Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients. Neurosci. Lett. 2004, 368:303-308.
99. Koschack J., Lütjohann D., Schmidt-Samoa C., Irle E. Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals. Neurobiol. Aging 2009, 30:898-902.
100. Krištofiková Z., Kříž Z., Rípová D., Koča J. Interactions of amyloid â peptide Z. Kristofiková, 1-40 and cerebrosterol. Neurochem. Res. 2012, 37:604-613.
101. Larrayoz I.M., Huang J.D., Lee J.W., Pascual I., Rodriguez I.R. 7-Ketocholesterol-induced inflammation: involvement of multiple kinase signaling pathways via NF kappa B but independently of reactive oxygen species formation. Invest. Ophthalmol. Visual Sci. 2010, 51:4942-4955.
102. Larsson H., Böttiger Y., Iuliano L., Diczfalusy U. In vivo interconversion of 7beta-hydroxycholesterol and 7-ketocholesterol, potential surrogate markers for oxidative stress. Free Radical Biol. Med. 2007, 43:695-701.
103. Leduc V., Jasmin-Bélanger S., Poirier J. APOE and cholesterol homeostasis in Alzheimer's disease. Trends Mol. Med. 2010, 16:469-477.
104. 2+ channel blockers. Neurochem. Res. 2007, 32:87-98.
105. Lemaire S., Lizard G., Monier S., Miguet C., Gueldry S., Volot F., Gambert P., Néel D. Different patterns of IL-1beta secretion, adhesion molecule expression and apoptosis induction in human endothelial cells treated with 7alpha-, 7beta-hydroxycholesterol, or 7-ketocholesterol. FEBS Lett. 1998, 440:434-439.
106. Lemaire-Ewing S., Prunet C., Montange T., Vejux A., Berthier A., Bessède G., Corcos L., Gambert P., Néel D., Lizard G. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol. Toxicol. 2005, 21:97-114.
107. Lemaire-Ewing S., Berthier A., Royer M.C., Logette E., Corcos L., Bouchot A., Monier S., Prunet C., Raveneau M., Rébé C., Desrumaux C., Lizard G., Néel D. 7beta-Hydroxycholesterol and 25-hydroxycholesterol-induced interleukin-8 secretion involves a calcium-dependent activation of c-fos via the ERK1/2 signaling pathway in THP-1 cells: oxysterols-induced IL-8 secretion is calcium-dependent. Cell Biol. Toxicol. 2009, 25:127-139.
108. Leonarduzzi G., Vizio B., Sottero B., Verde V., Gamba P., Mascia C., Chiarpotto E., Poli G., Biasi F. Early involvement of ROS overproduction in apoptosis induced by 7-ketocholesterol. Antioxid. Redox Signal. 2006, 8:375-380.
109. Leonarduzzi G., Gargiulo S., Gamba P., Perrelli M.G., Castellano I., Sapino A., Sottero B., Poli G. Molecular signaling operated by a diet-compatible mixture of oxysterols in up-regulating CD36 receptor in CD68 positive cells. Mol. Nutr. Food. Res. 2010, 54:S31-S41.
110. Leoni V., Caccia C. Oxysterols as biomarkers in neurodegenerative diseases. Chem. Phys. Lipids 2011, 164:515-524.
111. Li W., Ghosh M., Eftekhari S., Yuan X.M. Lipid accumulation and lysosomal pathways contribute to dysfunction and apoptosis of human endothelial cells caused by 7-oxysterols. Biochem. Biophys. Res. Commun. 2011, 409:711-716.
112. Lichtstein D., McGowan M.H., Russell P., Carper D.A. Digitalis and digitalis like compounds down-regulate gene expression of the intracellular signaling protein 14-3-3 in rat lens. Hypertens. Res. 2000, 23:S51-S53.
113. Liochev S.I. Reactive oxygen species and the free radical theory of aging. Free Radical Biol. Med. 2013, 60:1-4.
114. Liu H., Yuan L., Xu S., Zhang T., Wang K. Cholestane-3beta, 5alpha, 6beta-triol promotes vascular smooth muscle cells calcification. Life Sci. 2004, 76:533-543.
115. Liu Y., Sharpless N.E. Suppressor mechanisms in immune aging. Curr. Opin. Immunol. 2009, 21:431-439.
116. Liu H., Yuan L., Xu S., Wang K., Zhang T. Cholestane-3beta, 5alpha, 6beta-triol inhibits osteoblastic differentiation and promotes apoptosis of rat bone marrow stromal cells. J. Cell Biochem. 2005, 96:198-208.
117. Lizard G., Deckert V., Dubrez L., Moisant M., Gambert P., Lagrost L. Induction of apoptosis in endothelial cells treated with cholesterol oxides. Am. J. Pathol. 1996, 148:1625-1638.
118. López-Otín C., Blasco M.A., Partridge L., Serrano M., Kroemer G. The hallmarks of aging. Cell 2013, 153:1194-1217.
119. Lordan S., Mackrill J.J., O'Brien N.M. Oxysterols and mechanisms of apoptotic signaling: implications in the pathology of degenerative diseases. J. Nutr. Biochem. 2009, 20:321-336.
120. Lubos E., Handy D.E., Loscalzo J. Role of oxidative stress and nitric oxide in atherothrombosis. Front Biosci. 2008, 13:5323-5344.
121. Lund E., Kerr T.A., Sakai J., Li W.P., Russell D.W. cDNA cloning of mouse and human cholesterol 25-hydroxylases, polytoptic membrane proteins that synthesize a potent oxysterol regulator of lipid metabolism. J. Biol. Chem. 1998, 273:34316-34327.
122. Lund E.G., Guileyardo J.M., Russell D.W. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:7238-7243.
123. Luthra S., Fardin B., Dong J., Hertzog D., Kamjoo S., Gebremariam S., Butani V., Narayanan R., Mungcal J.K., Kuppermann B.D., Kenney M.C. Activation of caspase-8 and caspase-12 pathways by 7-ketocholesterol in human retinal pigment epithelial cells. Invest. Ophthalmol. Visual Sci. 2006, 47:5569-5675.
124. Lütjohann D., Papassotiropoulos A., Björkhem I., Locatelli S., Bagli M., Oehring R.D., Schlegel U., Jessen F., Rao M.L., von Bergmann K., Heun R. Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients. J. Lipid Res. 2000, 41:195-198.
125. Luu B. From cholesterol to oxysterols current data. C.R. Seances Soc. Biol. Fil. 1995, 189:827-837.
126. Malvitte L., Montange T., Vejux A., Joffre C., Bron A., Creuzot-Garcher C., Lizard G. Activation of a caspase-3-independent mode of cell death associated with lysosomal destabilization in cultured human retinal pigment epithelial cells (ARPE-19) exposed to 7beta-hydroxycholesterol. Curr. Eye Res. 2008, 33:769-781.
127. Marchant N.L., Reed B.R., Sanossian N., Madison C.M., Kriger S., Dhada R., Mack W.J., DeCarli C., Weiner M.W., Mungas D.M., Chui H.C., Jagust W.J. The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction. JAMA Neurol. 2013, 70:488-495.
128. Martin M.G., Ahmed T., Korovaichuk A., Venero C., Menchón S.A., Salas I., Munck S., Herreras O., Balschun D., Dotti C.G. Constitutive hippocampal cholesterol loss underlies poor cognition in old rodents. EMBO Mol. Med. 2014, 6:902-917.
129. Martin M., Dotti C.G., Ledesma M.D. Brain cholesterol in normal and pathological aging. Biochim. Biophys. Acta 2010, 1801:934-944.
130. Martin M.G., Perga S., Trovò L., Rasola A., Holm P., Rantamäki T., Harkany T., Castrén E., Chiara F., Dotti C.G. Cholesterol loss enhances TrkB signaling in hippocampal neurons aging in vitro. Mol. Biol. Cell. 2008, 19:2101-2112.
131. Mast N., White M.A., Bjorkhem I., Johnson E.F., Stout C.D., Pikuleva I.A. Crystal structures of substrate-bound and substrate-free cytochrome P450 46A1, the principal cholesterol hydroxylase in the brain. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:9546-9551.
132. Matsui H., Okumura K., Mukawa H., Hibino M., Toki Y., Ito T. Increased oxysterol contents in diabetic rat hearts: their involvement in diabetic cardiomyopathy. Can. J. Cardiol. 1997, 13:373-379.
133. Maulik M., Westaway D., Jhamandas J.H., Kar S. Role of cholesterol in APP metabolism and its significance in Alzheimer's disease pathogenesis. Mol. Neurobiol. 2013, 47:37-63.
134. +-ATPase inhibitors down-regulate gene expression of the intracellular signaling protein 14-3-3 in rat lens. J. Pharmacol. Exp. Ther. 1999, 289:1559-1563.
135. Menéndez-Carreño M., Varo N., Mugueta C., Restituto P., Ansorena D., Astiasarán I. Correlation between serum content of the main COPs (cholesterol oxidation products) from autoxidation and cardiovascular risk factors. Nutr. Hosp. 2011, 26:144-151.
136. Miguet C., Monier S., Bettaieb A., Athias A., Besséde G., Laubriet A., Lemaire S., Néel D., Gambert P., Lizard G. Ceramide generation occurring during 7beta-hydroxycholesterol- and 7-ketocholesterol-induced apoptosis is caspase independent and is not required to trigger cell death. Cell Death Differ. 2001, 8:83-99.
137. Min S.W., Sohn P.D., Cho S.H., Swanson R.A., Gan L. Sirtuins in neurodegenerative diseases: an update on potential mechanisms. Front. Aging Neurosci. 2013, 25(5):53.
138. Mintzer E., Charles G., Gordon S. Interaction of two oxysterols, 7-ketocholesterol and 25-hydroxycholesterol, with phosphatidylcholine and sphingomyelin in model membranes. Chem. Phys. Lipids 2010, 163:586-593.
139. Monier S., Samadi M., Prunet C., Denance M., Laubriet A., Athias A., Berthier A., Steinmetz E., Jürgens G., Nègre-Salvayre A., Bessède G., Lemaire-Ewing S., Néel D., Gambert P., Lizard G. Impairment of the cytotoxic and oxidative activities of 7beta-hydroxycholesterol and 7-ketocholesterol by esterification with oleate. Biochem. Biophys. Res. Commun. 2003, 303:814-824.
140. Monte M.J., Marin J.J., Antelo A., Vazquez-Tato J. Bile acids: chemistry, physiology, and pathophysiology. World J. Gastroenterol. 2009, 15:804-816.
141. Neekhra A., Luthra S., Chwa M., Seigel G., Gramajo A.L., Kuppermann B.D., Kenney M.C. Caspase-8 -12, and -3 activation by 7-ketocholesterol in retinal neurosensory cells. Invest. Ophthalmol. Visual Sci. 2007, 48:1362-1367.
142. Negre-Salvayre A., Auge N., Ayala V., Basaga H., Boada J., Brenke R., Chapple S., Cohen G., Feher J., Grune T., Lengyel G., Mann G.E., Pamplona R., Poli G., Portero-Otin M., Riahi Y., Salvayre R., Sasson S., Serrano J., Shamni O., Siems W., Siow R.C., Wiswedel I., Zarkovic K., Zarkovic N. Pathological aspects of lipid peroxidation. Free Radical Res. 2010, 44:1125-1171.
143. Nelson E.R., Wardell S.E., McDonnell D.P. The molecular mechanisms underlying the pharmacological actions of estrogens SERMs and oxysterols: implications for the treatment and prevention of osteoporosis. Bone 2013, 53:42-50.
144. Nury T., Samadi M., Zarrouk A., Riedinger J.M., Lizard G. Improved synthesis and in vitro evaluation of the cytotoxic profile of oxysterols oxidized at C4 (4α- and 4β-hydroxycholesterol) and C7 (7-ketocholesterol, 7α- and 7β-hydroxycholesterol) on cells of the central nervous system. Eur. J. Med. Chem. 2013, 70:558-567.
145. Nury T., Zarrouk A., Vejux A., Doria M., Riedinger J.M., Delage-Mourroux R., Lizard G. Induction of oxiapoptophagy, a mixed mode of cell death associated with oxidative stress, apoptosis and autophagy, on 7-ketocholesterol-treated 158N murine oligodendrocytes: impairment by α-tocopherol. Biochem. Biophys. Res. Commun. 2014, 446:714-719.
146. Odermatt A., Klusonova P. 11β-Hydroxysteroid dehydrogenase 1: regeneration of active glucocorticoids is only part of the story. J. Steroid Biochem. Mol. Biol. 2014, (pii: S0960-0760(14)00190-3). 10.1016/j.jsbmb.2014.08.011.
147. Okabe A., Urano Y., Itoh S., Suda N., Kotani R., Nishimura Y., Saito Y., Noguchi N. Adaptive responses induced by 24S-hydroxycholesterol through liver X receptor pathway reduce 7-ketocholesterol-caused neuronal cell death. Redox Biol. 2013, 2:28-35.
148. Olkkonen V.M., Li S. Oxysterol-binding proteins: sterol and phosphoinositide sensors coordinating transport, signaling and metabolism. Prog. Lipid Res. 2013, 52:529-538.
149. Otaegui-Arrazola A., Menendez-Carreno M., Ansorena D., Astiasaran I. Oxysterols: a world to explore. Food Chem. Toxicol. 2010, 48:3289-3303.
150. Papassotiropoulos A., Lütjohann D., Bagli M., Locatelli S., Jessen F., Rao M.L., Maier W., Björkhem I., von Bergmann K., Heun R. Plasma 24S-hydrox-ycholesterol, a peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease. Neuroreport 2000, 11:1959-1962.
151. Papassotiropoulos A., Streffer J., Tsolaki M., Schmid S., Thal D., Nicosia F., Iakovidou V., Maddalena A., Lutjohann D., Ghe-bremedhin E., Hegi T., Pasch T., Traxler M., Bruhl A., Benussi L., Binetti G., Braak H., Nitsch R., Hock C. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch. Neurol. 2003, 60:29-35.
152. Pedruzzi E., Guichard C., Ollivier V., Driss F., Fay M., Prunet C., Marie J.C., Pouzet C., Samadi M., Elbim C., O'dowd Y., Bens M., Vandewalle A., Gougerot-Pocidalo M.A., Lizard G., Ogier-Denis E. NAD(P)H oxidase Nox-4 mediates 7-ketocholesterol-induced endoplasmic reticulum stress and apoptosis in human aortic smooth muscle cells. Mol. Cell. Biol. 2004, 24:10703-10717.
153. Petit-Paitel A. GSK-3beta: a central kinase for neurodegenerative diseases?. Med. Sci. (Paris) 2010, 26:516-521.
154. Phan H.T., Hata T., Morita M., Yoda T., Hamada T., Vestergaard M.C., Takagi M. The effect of oxysterols on the interaction of Alzheimer's amyloid beta with model membranes. Biochim. Biophys. Acta 2013, 1828:2487-2495.
155. Pikuleva I.A. Cholesterol-metabolizing cytochromes P450. Drug Metab. Dispos. 2006, 34:513-520.
156. Pikuleva I.A., Curcio C.A. Cholesterol in the retina: the best is yet to come. Prog. Retin. Eye Res 2014, 41C:64-89.
157. Poli G., Biasi F., Leonarduzzi G. Oxysterols in the pathogenesis of major chronic diseases. Redox Biol. 2013, 1:125-130.
158. Pommier A.J., Alves G., Viennois E., Bernard S., Communal Y., Sion B., Marceau G., Damon C., Mouzat K., Caira F., Baron S., Lobaccaro J.M. Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells. Oncogene 2010, 29:2712-2723.
159. Prasanthi J.R., Huls A., Thomasson S., Thompson A., Schommer E., Ghribi O. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. Mol. Neurodegener. 2009, 4:1.
160. Prunet C., Montange T., Véjux A., Laubriet A., Rohmer J.F., Riedinger J.M., Athias A., Lemaire-Ewing S., Néel D., Petit J.M., Steinmetz E., Brenot R., Gambert P., Lizard G. Multiplexed flow cytometric analyses of pro- and anti-inflammatory cytokines in the culture media of oxysterol-treated human monocytic cells and in the sera of atherosclerotic patients. Cytometry A 2006, 69:359-373.
161. Prunet C., Petit J.M., Ecarnot-Laubriet A., Athias A., Miguet-Alfonsi C., Rohmer J.F., Steinmetz E., Néel D., Gambert P., Lizard G. High circulating levels of 7beta- and 7alpha-hydroxycholesterol and presence of apoptotic and oxidative markers in arterial lesions of normocholesterolemic atherosclerotic patients undergoing endarterectomy. Pathol. Biol. (Paris) 2006, 54:22-32.
162. Pulfer M.K., Taube C., Gelfand E., Murphy R.C. Ozone exposure in vivo and formation of biologically active oxysterols in the lung. J. Pharmacol. Exp. Ther. 2005, 312:256-264.
163. Ragot K., Delmas D., Athias A., Nury T., Baarine M., Lizard G. α-Tocopherol impairs 7-ketocholesterol-induced caspase-3-dependent apoptosis involving GSK-3 activation and Mcl-1 degradation on 158N murine oligodendrocytes. Chem. Phys. Lipids 2011, 164:469-478.
164. Ragot K., Mackrill J.J., Zarrouk A., Nury T., Aires V., Jacquin A., Athias A., Pais de Barros J.P., Véjux A., Riedinger J.M., Delmas D., Lizard G. Absence of correlation between oxysterol accumulation in lipid raft microdomains, calcium increase, and apoptosis induction on 158N murine oligodendrocytes. Biochem. Pharmacol. 2013, 86:67-79.
165. Reddy B.S., Martin C.W., Wynder E.L. Fecal bile acids and cholesterol metabolites of patients with ulcerative colitis, a high-risk group for development of colon cancer. Cancer Res. 1997, 37:1697-1701.
166. Reddy B.S., Watanabe K. Effect of cholesterol metabolites and promoting effect of lithocholic acid in colon carcinogenesis in germ-free and conventional F344 rats. Cancer Res. 1979, 39:1521-1524.
167. Reed B., Villeneuve S., Mack W., DeCarli C., Chui H.C., Jagust W. Associations between serum cholesterol levels and cerebral amyloidosis. JAMA Neurol. 2014, 71:195-200.
168. Richardson J.A., Amantea C.M., Kianmahd B., Tetradis S., Lieberman J.R., Hahn T.J., Parhami F. Oxysterol-induced osteoblastic differentiation of pluripotent mesenchymal cells is mediated through a PKC- and PKA-dependent pathway. J. Biol. Chem. 2007, 100:1131-1145.
169. Riggs B.L., Melton L.J. The prevention and treatment of osteoporosis. New Engl. J. Med. 1992, 327:620-627.
170. Robbins D.J., Fei D.L., Riobo N.A. The Hedgehog signal transduction network. Sci. Signal. 2012, 5(246):re6.
171. Roher A.E., Weiss N., Kokjohn T.A., Kuo Y.M., Kalback W., Anthony J., Watson D., Luehrs D.C., Sue L., Walker D., Emmerling M., Goux W., Beach T. Increased A beta peptides and reduced cholesterol and myelin proteins characterize white matter degeneration in Alzheimer's disease. Biochemistry 2002, 41:11080-11090.
172. Romeo G.R., Kazlauskas A. Oxysterol and diabetes activate STAT3 and control endothelial expression of profilin-1 via OSBP1. J. Biol. Chem. 2008, 283:9595-9605.
173. Royer M.C., Lemaire-Ewing S., Desrumaux C., Monier S., Pais de Barros J.P., Athias A., Néel D., Lagrost L. 7-ketocholesterol incorporation into sphingolipid/cholesterol-enriched (lipid raft) domains is impaired by vitamin E: a specific role for alpha-tocopherol with consequences on cell death. J. Biol. Chem. 2009, 284:15826-15834.
174. Rudkowska I. Plant sterols and stanols for healthy ageing. Maturitas 2010, 66:158-162.
175. Rudolf M., Curcio C.A. Esterified cholesterol is highly localized to Bruch's membrane, as revealed by lipid histochemistry in wholemounts of human choroid. J. Histochem. Cytochem. 2009, 57:731-739.
176. Ruiz J.L., Fernandes L.R., Levy D., Bydlowski S.P. Interrelationship between ATP-binding cassette transporters and oxysterols. Biochem. Pharmacol. 2013, 86:80-88.
177. Rujoi M., Jin J., Borchman D., Tang D., Yappert M.C. Isolation and lipid characterization of cholesterol-enriched fractions in cortical and nuclear human lens fibers. Invest. Ophthalmol. Visual Sci. 2003, 44:1634-1642.
178. Russell D.W. Oxysterol biosynthetic enzymes. Biochim. Biophys. Acta 2000, 1529:126-135.
179. Savouret J.F., Antenos M., Quesne M., Xu J., Milgrom E., Casper R.F. 7-ketocholesterol is an endogenous modulator for the arylhydrocarbon receptor. J. Biol. Chem. 2001, 276:3054-3059.
180. Schenck G.O., Gollnick K., Neümuller O.A. Photosensitized autoxidation of steroids preparation of steroid hydroperoxides by means of phototoxic photosentitizers. Liebigs Ann. 1957, 603:46.
181. Schmitz G., Grandl M. Lipid homeostasis in macrophages-implications for atherosclerosis. Rev. Physiol. Biochem. Pharmacol. 2008, 160:93-125.
182. Schmitz G., Grandl M. Endolysosomal phospholipidosis and cytosolic lipid droplet storage and release in macrophages. Biochim. Biophys. Acta 2009, 1791:524-539.
183. Schmitz G., Müller G. Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. J. Lipid Res. 1991, 32:1539-1570.
184. Schreurs B.G., Smith-Bell C.A., Lemieux S.K. Dietary cholesterol increases ventricular volume and narrows cerebrovascular diameter in a rabbit model of Alzheimer's disease. Neuroscience 2013, 254:61-69.
185. Schroepfer G.J. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol. Rev. 2000, 80:361-554.
186. Schweizer R.A., Zürcher M., Balazs Z., Dick B., Odermatt A. Rapid hepatic metabolism of 7-ketocholesterol by 11beta-hydroxysteroid dehydrogenase type 1: species-specific differences between the rat, human, and hamster enzyme. J. Biol. Chem. 2004, 279:18415-18424.
187. Sharma K., Sharma N.K., Anand A. Why AMD is a disease of ageing and not of development: mechanisms and insights. Front. Aging Neurosci. 2014, 6:151.
188. Shibata N., Glass C.K. Macrophages, oxysterols and atherosclerosis. Circ. J. 2010, 74:2045-2051.
189. Silva J., Beckedorf A., Bieberich E. Osteoblast-derived oxysterol is a migration-inducing factor for human breast cancer cells. J. Biol. Chem. 2003, 278:25376-25385.
190. Silvente-Poirot S., Poirot M. Cancer. Cholesterol and cancer, in the balance. Science 2014, 343:1445-1446.
191. Simons M., Keller P., De Strooper B., Beyreuther K., Dotti C.G., Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:6460-6464.
192. Slevin M., Krupinski J., Badimon L. Controlling the angiogenic switch in developing atherosclerotic plaques: possible targets for therapeutic intervention. J. Angiogenes Res. 2009, 1:4.
193. Smiljanic K., Vanmierlo T., Djordjevic A.M., Perovic M., Loncarevic-Vasiljkovic N., Tesic V., Rakic L., Ruzdijic S., Lutjohann D., Kanazir S. Aging induces tissue-specific changes in cholesterol metabolism in rat brain and liver. Lipids 2013, 48:1069-1077.
194. Smith L.L. Cholesterol autoxidation 1981-1986. Chem. Phys. Lipids 1987, 44:87-125.
195. Smith L.L., Smart V.B., Ansari G.A. Mutagenic cholesterol preparations. Mutat. Res. 1979, 68:23-30.
196. Söderberg M., Edlund C., Kristensson K., Dallner G. Lipid compositions of different regions of the human brain during aging. J. Neurochem. 1990, 54:415-423.
197. Solomon A., Leoni V., Kivipelto M., Besga A., Oksengard A., Julin P., Svensson L., Wahlund L., Andreasen N., Winblad B., Soininen H., Bjorkhem I. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairments but not with Alzheimer's disease. Neurosci. Lett. 2009, 462:89-93.
198. Spann N.J., Glass C.K. Sterols and oxysterols in immune cell function. Nat. Immunol. 2013, 14:893-900.
199. Sparks D.L., Scheff S.W., Hunsaker J.C., Liu H., Landers T., Gross D.R. Induction of Alzheimer-like beta-amyloid immunoreactivity in the brains of rabbits with dietary cholesterol. Exp. Neurol. 1994, 126:88-94.
200. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiology 2004, 84:1381-1478.
201. Svennerholm L., Boström K., Jungbjer B., Olsson L. Membrane lipids of adult human brain: lipid composition of frontal and temporal lobe in subjects of age 20 to 100 years. J. Neurochem. 1994, 63:1802-1811.
202. Terlecky S.R., Koepke J.I., Walton P.A. Peroxisomes and aging. Biochim. Biophys. Acta 2006, 1763:1749-1754.
203. Testa G., Gamba P., Badilli U., Gargiulo S., Maina M., Guina T., Calfapietra S., Biasi F., Cavalli R., Poli G., Leonarduzzi G. Loading into nanoparticles improves quercetin's efficacy in preventing neuroinflammation induced by oxysterols. PLoS One 2014, 9(5):e96795.
204. Thirumangalakudi L., Prakasam A., Zhang R., Bimonte-Nelson H., Sambamurti K., Kindy M.S., Bhat N.R. High cholesterol-induced neuroinflammation and amyloid precursor protein processing correlate with loss of working memory in mice. J. Neurochem. 2008, 106:475-485.
205. Titorenko V.I., Terlecky S.R. Peroxisome metabolism and cellular aging. Traffic 2011, 12:252-259.
206. Tosato M., Zamboni V., Ferrini A., Cesari M. The aging process and potential interventions to extend life expectancy. Clin. Interventions Aging 2007, 2:401-412.
207. Tousoulis D., Kampoli A.M., Tentolouris C., Papageorgiou N., Stefanadis C. The role of nitric oxide on endothelial function. Curr. Vasc. Pharmacol. 2012, 10:4-18.
208. Trousson A., Bernard S., Petit P.X., Liere P., Pianos A., El Hadri K., Lobaccaro J.M., Ghandour M.S., Raymondjean M., Schumacher M., Massaad C. 25-Hydroxycholesterol provokes oligodendrocyte cell line apoptosis and stimulates the secreted phospholipase A2 type IIA via LXR beta and PXR. J. Neurochem. 2009, 109:945-958.
209. Vaya J., Schipper H.M. Oxysterols, cholesterol homeostasis, and Alzheimer disease. J. Neurochem. 2007, 102:1727-1737.
210. Vaya J., Szuchman A., Tavori H., Aluf Y. Oxysterols formation as a reflection of biochemical pathways: summary of in vitro and in vivo studies. Chem. Phys. Lipids 2011, 164:438-442.
211. Vejux A., Kahn E., Dumas D., Bessède G., Ménétrier F., Athias A., Riedinger J.M., Frouin F., Stoltz J.F., Ogier-Denis E., Todd-Pokropek A., Lizard G. 7-Ketocholesterol favors lipid accumulation and colocalizes with Nile Red positive cytoplasmic structures formed during 7-ketocholesterol-induced apoptosis: analysis by flow cytometry FRET biphoton spectral imaging microscopy, and subcellular fractionation. Cytometry A 2005, 64:87-100.
212. Vejux A., Guyot S., Montange T., Riedinger J.M., Kahn E., Lizard G. Phospholipidosis and down-regulation of the PI3-K/PDK-1/Akt signalling pathway are vitamin E inhibitable events associated with 7-ketocholesterol-induced apoptosis. J. Nutr. Biochem. 2009, 20:45-61.
213. Vejux A., Lizard G. Cytotoxic effects of oxysterols associated with human diseases: induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol. Aspects Med. 2009, 30:153-170.
214. Vejux A., Samadi M., Lizard G. Contribution of cholesterol and oxysterols in the physiopathology of cataract: implication for the development of pharmacological treatments. J. Ophthalmol. 2011, 2011:471947.
215. Vrensen G.F. Early cortical lens opacities: a short overview. Acta Ophtalmol 2009, 87:602-610.
216. Vuorinen M., Solomon A., Rovio S., Nieminen L., Kåreholt I., Tuomilehto J., Soininen H., Kivipelto M. Changes in vascular risk factors from midlife to late life and white matter lesions: a 20-year follow-up study. Dement. Geriatr. Cogn. Disord. 2011, 31:119-125.
217. Vurusaner B., Gamba P., Testa G., Gargiulo S., Biasi F., Zerbinati C., Iuliano L., Leonarduzzi G., Basaga H., Poli G. Survival signaling elicited by 27-hydroxycholesterol through the combined modulation of cellular redox state and ERK/Akt phosphorylation. Free Radical Biol. Med. 2014, (pii: S0891-5849(14)00343-8). 10.1016/j.freeradbiomed.2014.07.026.
218. Wang J., Megha London E. Relationship between sterol/steroid structure and participation in ordered lipid domains (lipid rafts): implications for lipid raft structure and function. Biochemistry 2004, 43:1010-1018.
219. Wang S.F., Chou Y.C., Mazumder N., Kao F.J., Nagy L.D., Guengerich F.P., Huang C., Lee H.C., Lai P.S., Ueng Y.F. 7-Ketocholesterol induces P-glycoprotein through PI3K/mTOR signaling in hepatoma cells. Biochem. Pharmacol. 2013, 86:548-560.
220. Wentworth P., Nieva J., Takeuchi C., Galve R., Wentworth A.D., Dilley R.B., De Laria G.A., Saven A., Babior B.M., Janda K.D., Eschenmoser A., Lerner R.A. Evidence for ozone formation in human atherosclerotic arteries. Science 2003, 302:1053-1056.
221. Wood W.G., Li L., Müller W.E., Eckert G.P. Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis. J. Neurochem. 2014, 129:559-572.
222. Woodruff-Pak D.S., Agelan A., Del Valle L. A rabbit model of Alzheimer's disease: valid at neuropathological, cognitive, and therapeutic levels. J. Alzheimers Dis. 2007, 11:371-383.
223. Yoon J.H., Canbay A.E., Werneburg N.W., Lee S.P., Gores G.J. Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: implications for biliary tract carcinogenesis. Hepatology 2004, 39:732-738.
224. Yuan X.M., Li W., Brunk U.T., Dalen H., Chang Y.H., Sevanian A. Lysosomal destabilization during macrophage damage induced by cholesterol oxidation products. Free Radical Biol. Med. 2000, 28:208-218.
225. Zigman S., Paxhia T., Marinetti G., Girsch S. Lipids of human lens fiber cell membranes. Curr. Eye Res. 1984, 3:887-896.
226. Zonta B., Minichiello L. Synaptic membrane rafts: traffic lights for local neurotrophin signaling?. Front. Synaptic Neurosci. 2013, 5(9).
227. Zuliani G., Donnorso M.P., Bosi C., Passaro A., Dalla Nora E., Zurlo A., Bonetti F., Mozzi A.F., Cortese C. Plasma 24S-hydroxycholesterol levels in elderly subjects with late onset Alzheimer's disease or vascular dementia: a case control study. BMC Neurol. 2011, 11:121.